These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31973101)

  • 1. Centering Patient Expectations of a Novel Home-Based Oral Drug Treatment among
    Lee SJ; Apio RJ; Palmer JJ
    Trop Med Infect Dis; 2020 Jan; 5(1):. PubMed ID: 31973101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
    Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
    Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole.
    Neau P; Hänel H; Lameyre V; Strub-Wourgaft N; Kuykens L
    Trop Med Infect Dis; 2020 Jan; 5(1):. PubMed ID: 32012658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
    Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
    Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fexinidazole: First Global Approval.
    Deeks ED
    Drugs; 2019 Feb; 79(2):215-220. PubMed ID: 30635838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human African Trypanosomiasis: Progress and Stagnation.
    Bottieau E; Clerinx J
    Infect Dis Clin North Am; 2019 Mar; 33(1):61-77. PubMed ID: 30712768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
    Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
    Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human African Trypanosomiasis (Sleeping Sickness)-Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention.
    Ortiz-Martínez Y; Kouamé MG; Bongomin F; Lakoh S; Henao-Martínez AF
    Curr Trop Med Rep; 2023 Dec; 10(4):222-234. PubMed ID: 38939748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative form of melarsoprol in sleeping sickness.
    Kennedy PG
    Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda's human African trypanosomiasis elimination programme.
    Lee SJ; Palmer JJ
    Infect Dis Poverty; 2018 Aug; 7(1):84. PubMed ID: 30119700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy against human African trypanosomiasis: is there a road to success?
    Burri C
    Parasitology; 2010 Dec; 137(14):1987-94. PubMed ID: 20961469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination.
    Simarro PP; Franco JR; Diarra A; Ruiz Postigo JA; Jannin J
    Res Rep Trop Med; 2013; 4():1-6. PubMed ID: 30100778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story.
    Dickie EA; Giordani F; Gould MK; Mäser P; Burri C; Mottram JC; Rao SPS; Barrett MP
    Trop Med Infect Dis; 2020 Feb; 5(1):. PubMed ID: 32092897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection and treatment of human African trypanosomiasis.
    Bouteille B; Buguet A
    Res Rep Trop Med; 2012; 3():35-45. PubMed ID: 30890865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
    Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
    J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fexinidazole for the treatment of human African trypanosomiasis.
    Fairlamb AH
    Drugs Today (Barc); 2019 Nov; 55(11):705-712. PubMed ID: 31840685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
    Kennedy PGE; Rodgers J
    Front Immunol; 2019; 10():39. PubMed ID: 30740102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.